Elan, Abbott End Ranbaxy Suit Over Generic TriCor
By Richard Vanderford ( February 28, 2011, 7:40 PM EST) -- Elan Pharma International Ltd. and Abbott Laboratories on Friday ended a patent infringement suit in New Jersey over Ranbaxy Inc.'s plans to introduce a generic version of cholesterol drug TriCor....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.